Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention

In patients with manifestations of cardiovascular disease, acetylsalicylic acid (popularly known as aspirin) has been the mainstay of treatment for decades owing to its capacity to reduce the risk of ischaemic events. Accordingly, novel antithrombotic therapies have been traditionally tested on a ba...

Celý popis

Podrobná bibliografie

Vydáno v:	Nature reviews cardiology Ročník 15; číslo 8; s. 480 - 496
Hlavní autoři:	Capodanno, Davide, Mehran, Roxana, Valgimigli, Marco, Baber, Usman, Windecker, Stephan, Vranckx, Pascal, Dangas, George, Rollini, Fabiana, Kimura, Takeshi, Collet, Jean-Philippe, Gibson, C Michael, Steg, Philippe Gabriel, Lopes, Renato D, Gwon, Hyeon-Cheol, Storey, Robert F, Franchi, Francesco, Bhatt, Deepak L, Serruys, Patrick W, Angiolillo, Dominick J
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England Nature Publishing Group 01.08.2018
Témata:	Acids Aspirin - therapeutic use Cardiovascular disease Cardiovascular Diseases - drug therapy Cardiovascular Diseases - prevention & control Disease prevention Fibrinolytic Agents - therapeutic use Humans Stroke Stroke - drug therapy Stroke - prevention & control
ISSN:	1759-5002, 1759-5010, 1759-5010
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!